A Randomized, Open-Label, Parallel-group, Multicenter Phase 1/2 Study to Evaluate the Safety and Exploratory Efficacy of NT-101 Topical Ophthalmic Solution in Patients with Wet Age-Related Macular Degeneration (AMD)
Clinical Trial Grant
Administered By
Ophthalmology, Vitreoretinal Diseases & Surgery
Awarded By
NexThera Co., Ltd.
Start Date
February 25, 2025
End Date
February 28, 2030
Administered By
Ophthalmology, Vitreoretinal Diseases & Surgery
Awarded By
NexThera Co., Ltd.
Start Date
February 25, 2025
End Date
February 28, 2030